U.S. market Closed. Opens in 2 hours 36 minutes

STXS | Stereotaxis, Inc. Stock Overview

(Stock Exchange: AMEX)
Day's Range 2.0100 - 2.0510
52 Week Range 1.5100 - 3.29
Beta 1.48
Implied Volatility 136.74%
IV Rank 46.41%
Day's Volume 222,782
Average Volume 240,776
Shares Outstanding 84,729,500
Market Cap 172,000,885
Sector Healthcare
Industry Medical - Instruments & Supplies
IPO Date 2004-08-12
Valuation
Profitability
Growth
Health
P/E Ratio -7.52
Forward P/E Ratio N/A
EPS -0.27
1YR Price Target N/A
Dividend Yield N/A
Dividend Per Share N/A
Dividend ExDate N/A
Dividend PayDate N/A
Employees 122
Country USA
Website STXS
Stereotaxis, Inc. designs, manufactures, and markets robotic systems, instruments, and information systems for the interventional laboratory in the United States and internationally. Its robotic magnetic navigation (RMN) systems include the Genesis RMN and Niobe systems, which enable physicians to complete complex interventional procedures by providing image-guided delivery of catheters and guidewires through the blood vessels and chambers of the heart to treatment sites. The company also provides Odyssey, a real-time information solution to manage, control, record, and share procedures across networks; and Stereotaxis Imaging Model S X-ray system, a single-plane full-power x-ray system, including c-arm, powered table, motorized boom, and large high-definition monitors for a robotic interventional operating room. In addition, it offers disposables and other accessories, such as QuikCAS automated catheter advancement disposables for the remote advancement of electrophysiology catheters; and CARTO RMT navigation and ablation system, CELSIUS RMT, NAVISTAR RMT, NAVISTAR RMT DS, NAVISTAR RMT THERMOCOOL, and CELSIUS RMT THERMOCOOL irrigated tip diagnostic/ablation steerable tip catheters. Further, the company provides Vdrive, a system that offers navigation and stability for the diagnostic and therapeutic devices designed to improve interventional procedures; and V-Loop, V-Sono, and V-CAS disposable components. Stereotaxis, Inc. markets its products through direct sales force, distributors, and sales agents. The company has a strategic collaboration with Osypka AG to develop a magnetic ablation catheter using Stereotaxis' robotic technology. Stereotaxis, Inc. was incorporated in 1990 and is headquartered in Saint Louis, Missouri.
STXS's peers: BNGO, ISRG, POAI, ARAY, ANGO, CUTR, ATRC, EDAP, LUCY
*Chart delayed
Analyzing fundamentals for STXS we got that it has weak fundamentals where Valuation is considered to be significantly overvalued, Profitability is unacceptably poor, Growth is desperately bad and Health is very weak. For more detailed analysis please see STXS Fundamentals page.

Watching at STXS technicals we can see that long-term trend is bearish, while middle-term trend is bullish, as well as bullish short-term trend. More technicals details can be found on STXS Technicals page.
An error has occurred. This application may no longer respond until reloaded. Reload 🗙